Overview
Steven Larmon is a Hematologist Oncology specialist and a Hematologist in Keene, New Hampshire. Dr. Larmon is rated as an Experienced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Dartmouth-Hitchcock Clinic
Sergey Devitskiy is a Hematologist Oncology specialist and a Hematologist in Lebanon, New Hampshire. Dr. Devitskiy is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Clear Cell Sarcoma. Dr. Devitskiy is currently accepting new patients.
Douglas Weckstein is a Hematologist Oncology specialist and an Oncologist in Concord, New Hampshire. Dr. Weckstein is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. His top areas of expertise are Lung Cancer, Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Prostatectomy.
Umass Memorial Medical Group Inc
Kriti Mittal is a Hematologist Oncology specialist and a Hematologist in Worcester, Massachusetts. Dr. Mittal is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), and Muscle Invasive Bladder Cancer. Dr. Mittal is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Larmon isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung AdenocarcinomaDr. Larmon isDistinguished. Learn about Lung Adenocarcinoma.
- Small Cell Lung Cancer (SCLC)Dr. Larmon isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Larmon isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Chronic Lymphocytic Leukemia (CLL)
- EGFR Positive Lung CancerDr. Larmon isAdvanced. Learn about EGFR Positive Lung Cancer.
- Familial Prostate CancerDr. Larmon isAdvanced. Learn about Familial Prostate Cancer.
- Inflammatory Breast CancerDr. Larmon isAdvanced. Learn about Inflammatory Breast Cancer.
- Large-Cell Lung CarcinomaDr. Larmon isAdvanced. Learn about Large-Cell Lung Carcinoma.
- Multiple MyelomaDr. Larmon isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Adult Immune ThrombocytopeniaDr. Larmon isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Larmon isExperienced. Learn about Anemia.
- AngiosarcomaDr. Larmon isExperienced. Learn about Angiosarcoma.
- Bladder CancerDr. Larmon isExperienced. Learn about Bladder Cancer.
- Blood ClotsDr. Larmon isExperienced. Learn about Blood Clots.
- Breast CancerDr. Larmon isExperienced. Learn about Breast Cancer.